OVID
Ovid Therapeutics Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:36:18 AM EST
2.24USD-0.885%(-0.02)40,132
Pre-marketNov 19, 2026 8:00:30 AM EST
2.30USD+1.770%(+0.04)
OVID Financials
In Q3 FY 2026 (ended ), Ovid Therapeutics Inc. Common Stock (OVID) reported revenue of $0, net income of −$20.78M, operating cash flow of −$15.88M, and assets of $222.24M (filed ).
Loading financial statements…
